The role of multi-parametric magnetic resonance imaging (MRI) in early prediction of malignant transformation of low-grade Gliomas (A Systematic review)

Danfulani Mohammed; Ahmad Aliyu Shamsuddeen

doi:10.30574/gscarr.2020.5.3.0122

Authors

Danfulani Mohammed Department of Radiology, Faculty of Clinical Sciences, Usmanu Danfodiyo University Sokoto, Nigeria.
Ahmad Aliyu Shamsuddeen Department of Radiology, Faculty of Clinical Sciences, Usmanu Danfodiyo University Sokoto, Nigeria.

DOI:

https://doi.org/10.30574/gscarr.2020.5.3.0122

Keywords:

Magnetic resonance imaging (MRI), Low-grade gliomas (LGGs), Histology, Biopsy, Immuno-histochemistry

Abstract

Introduction: Low-grade gliomas is the most common primary brain tumour, although the presentation may take up to two decades, there is high tendency of early malignant transformation which raise a growing concern. Multi-parametric MRI studies have the potential for predicting the early malignant transformation.

Methods: A comprehensive electronic search of various databases was conducted together with forward tracking of the reference list to retrieve relevant qualitative primary studies. Moreover, hand search for journal that was not available electronically was also conducted. Through assessment of the relevant studies was ensured and the included studies were carefully selected. The relevant data was extracted by data extraction form recommended by Cochrane collaborations.

Results: The search yielded 1158 which was narrowed down to eight (8) studies that satisfied the inclusion criteria. These studies are assessing the role of different MRI parameters in predicting the early malignant transformation of Low-grade gliomas. The risk of bias and the applicability concern of the included studies are low.

Conclusion: Based on the findings of this review; Multi-parametric MRI studies have the potential of predicting the early malignant transformation of low-grade gliomas. There is need for high quality large scale, prospective studies on the role of multi-parametric MRI studies in early prediction of malignant transformation of LGGs and meta-analysis of these studies is highly recommended.

Metrics

Metrics Loading ...

References

Grier JT, Batchelor T. Low-Grade Gliomas in Adults. The Oncologist. 2006; 11: 681-693.

Brodal P. Central Nervous System Structure And Function. 2010.

Smith C, Ironside JW. Diagnosis and pathogenesis of gliomas. Current Diagnostic Pathology. 2007; 13: 180-192.

Sanai N, Chang S, Berger MS. Low-Grade Gliomas In Adults. Journal Of Neurosurgery. 2011; 115: 948-965.

Kao HW, Chiang SW, Chung HW, Tsai FY, Chen CY. Advanced MR imaging of gliomas: an update. BioMed research international. 2013; 970586.

Kros JM. WHO Guidelines for Diagnosis of Glial Tumours: What Is Old and What Is New? European Association of NeuroOncology Magazine. 2011; 1: 9-12.

Caseiras GB, Chheang S, Babb J, Rees JH, Pecerrelli N, Tozer DJ, Benton C, Zagzag D, Johnson G, Waldman AD, Jäger HR, Law M. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. European Journal of Radiology. 2010; 73: 215-220.

Soffietti R, Baumert BG, BelloL, Von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W. Guidelines on management of low-grade gliomas: report of an EFNS–EANO* Task Force. European Journal of Neurology. 2010; 17: 1124-1133.

Pouratian N, Schiff D. Management of low-grade glioma. Current neurology and neuroscience reports. 2010; 10: 224-231.

Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC, Capelle L. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Annals of neurology. 2003; 53: 524-528.

Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. Journal of Clinical Oncology. 2008; 26(8):1338-45.

Soffietti R, Baumert B, Bello L, Von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang‐Xuan K. Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force. European journal of neurology. 2010; 17: 1124-1133.

Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, CrinièreE, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broët P, Sanson M, Delattre JY. Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions. Journal of Clinical Oncology. 2004; 22: 3133-3138.

Blonski M, Taillandier L, Herbet G, Maldonado I, Beauchesne P, Fabbro M, Campello C, Gozé C, Rigau V, Moritz-Gasser S, Kerr C, Rudà R, Soffietti R, Bauchet L, Duffau H. Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. Journal of Neuro-Oncology. 2012; 106: 353-366.

Klein M, Engelberts NH, Van Der Ploeg HM, Kasteleijn‐Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ. Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life. Annals of neurology. 2003; 54: 514-520.

Sahin N, Melhem ER, Wang S, Krejza J, Poptani H, Chawla S, Verma G. Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: Perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade. Neuroradiology Journal. 2013; 26: 531-541.

Chawalparit O, Sangruchi T, Witthiwej T, Sathornsumetee S, Tritrakarn S, Piyapittayanan S, Chaicharoen P, Direksunthorn T, Charnchaowanish P. Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2013; 96: 1365-1373.

Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Baddrudoja MA, Krouwer HG. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. American Journal of Neuroradiology. 2004; 25: 1524-1532.

Karatağ O, Karatağ GY, Uysal E, Can SM, Ertürk M, Başak M. Can Magnetic Resonance Spectroscopy Adequately Differentiate Neoplastic From Non-Neoplastic And Low-Grade From High-Grade Lesions In Brain Masses? Marmara Medical Journal. 2010; 23: 326-338.

Mcknight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. Journal of neurosurgery. 2007; 106: 660-666.

Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z. Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease? American Journal of Neuroradiology. 2009; 30: 681-688.

Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR. Low-Grade Gliomas: Do Changes in rCBV Measurements at Longitudinal Perfusion-weighted MR Imaging Predict Malignant Transformation? Radiology. 2008; 247: 170-178.

Majchrzak K, Kaspera W, Bobek-Billewicz B, Hebda A, Stasik-Pres G, Majchrzak H, Ladzinski P. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study. Clin Neurol Neurosurg. 2012;114: 1135-44.

Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC, Capelle L. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Annals of Neurology. 2003; 53: 524-528.

Klein M, Heimans J, Aaronson N, Van Der Ploeg H, Grit J, Muller M, Postma T, Mooij J, Boerman R,Beute G. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. The lancet. 2002;360: 1361-1368.

Revman RM. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration. 2003.

Higgins Jpt GSE. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. 2009.

Whiting P, RA, Reitsma Jb, Bossuyt Pm, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology. 2003; 3: 25.

Reitsma Jb, RA, Whiting P, Vlassov Vv, Leeflang, Mmg DJ. Chapter 9: Assessing methodological quality. Deeks JJ, Bossuyt PM, Gatsonis C (editors),. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration. 2009.

Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G. Low-Grade Gliomas: Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging—Prediction of Patient Clinical Response. Radiology. 2006; 238:658-667.

Rees J, Watt H, Jager HR, Benton C, Tozer D, Tofts P, Waldman A. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol. 2009; 72: 54-64.

Brasil Caseiras G, Ciccarelli O, Altmann DR, Benton CE, Tozer DJ, Tofts PS, Yousry TA, Rees J, Waldman AD, Jäger HR. Low-Grade Gliomas: Six-month Tumor Growth Predicts Patient Outcome Better than Admission Tumor Volume, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient. Radiology. 2009; 253: 505-512.

Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F. Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. Journal of Neuro-Oncology. 2010; 97: 73-80.

Alimenti A, Delavelle J, Lazeyras F, Yilmaz H, Dietrich PY, De Tribolet N, Lövblad KO. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas. European neurology. 2007;58:198-209.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D. Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging. American Journal of Neuroradiology. 2003; 24:1989-1998.

Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA. Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment. Radiology. 2000; 217: 377-384.

Surma-Aho O, Niemelä M, Vilkki J, Kouri M, Brander A, Salonen O, Paetau A, Kallio M, J Pyykkönen L, Jääskeläinen J. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 2001; 56: 1285-1290.